Literature DB >> 2528696

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

C L Joachim1, H Mori, D J Selkoe.   

Abstract

Alzheimer's disease is the most common cause of progressive intellectual failure in aged humans. The filamentous brain lesions which define the disease occur within neurons (neurofibrillary tangles), in extracellular cerebral deposits (amyloid plaques) and in meningocerebral blood vessels (amyloid angiopathy). They are found in lesser numbers in the brains of virtually all old humans. A protein with a relative molecular mass (Mr) of approximately 4,000, designated amyloid beta-protein or amyloid A4 protein, is the subunit of the vascular and plaque amyloid filaments in individuals with Alzheimer's disease, normal ageing and trisomy 21 (Down's syndrome). The amyloid beta-protein is a small fragment of a membrane-associated glycoprotein, encoded by a gene on human chromosome 21 which is telomeric to a genetic defect that causes at least some cases of familial Alzheimer's disease. Until now, the pathological lesions of the disease have been found only in the brain, although reports of phenotypic abnormalities in non-neural tissues have suggested that Alzheimer's disease may be a widespread, systemic disorder. Here we report the detection of amyloid beta-protein deposits in non-neural tissues and blood vessels of Alzheimer's disease patients, including skin, subcutaneous tissue and intestine. The protein was also present in non-neural tissues in a proportion of aged, normal subjects. Our findings indicate that a principal feature of the disease process is expressed subclinically in tissues other than brain. The occurrence of amyloid beta-protein deposits in multiple tissues suggests that the protein may be produced locally in numerous organs or may, as in other human amyloidoses, be derived from a common circulating precursor. These observations affect the rationale for many experiments analysing the amyloid beta-protein precursor and its messenger RNAs in Alzheimer's disease brain tissue and have major implications for the pathogenesis and treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528696     DOI: 10.1038/341226a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  102 in total

1.  Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

Authors:  S A Frautschy; G M Cole; A Baird
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

2.  Immunohistochemical localization of the proteinase inhibitor region of amyloid precursor proteins in the neocortex of Alzheimer's disease and aged controls.

Authors:  S Nakamura; T Suenaga; I Akiguchi; J Kimura; S Nakamura; Y Tokushima; N Kitaguchi; Y Takahashi; S Shiojiri
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Snakes as veterinary emblems.

Authors:  K B Haas
Journal:  Vet Herit       Date:  1994-06

4.  Amyloid precursor protein expression modulates intestine immune phenotype.

Authors:  Kendra L Puig; Adam J Swigost; Xudong Zhou; Mary Ann Sens; Colin K Combs
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

5.  Stimulated platelets release amyloid beta-protein precursor.

Authors:  G M Cole; D Galasko; I P Shapiro; T Saitoh
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

6.  Insulin detemir is not transported across the blood-brain barrier.

Authors:  William A Banks; John E Morley; Jessica L Lynch; Kristin M Lynch; Arshag D Mooradian
Journal:  Peptides       Date:  2010-09-22       Impact factor: 3.750

7.  Role of amyloid β in the induction of lipolysis and secretion of adipokines from human adipose tissue.

Authors:  Zhongxiao Wan; Dorrian Mah; Svetlana Simtchouk; Andreas Kluftinger; Jonathan P Little
Journal:  Adipocyte       Date:  2014-12-31       Impact factor: 4.534

Review 8.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 9.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

10.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

Authors:  Judith Miklossy; Hong Qing; Aleksandra Radenovic; Andras Kis; Bertrand Vileno; Forró Làszló; Lisa Miller; Ralph N Martins; Gerard Waeber; Vincent Mooser; Fred Bosman; Kamel Khalili; Nune Darbinian; Patrick L McGeer
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.